OTS/ohcm position classification support services - EO 14398
Active Awarded Last action
- Contract number
- 75F40126F19039
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,563,773
Award facts
- Contract value 54% obligated
-
- $1,563,772.80 Current, with exercised options
- $2,910,067.20 Potential, with all options
- Completion date 4% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a $2.91 million delivery order to Kaiva Strategies, LLC on September 30, 2026, under the Professional, Administrative, and Consulting Services (PACS) IDIQ for position classification support services related to Executive Order 14398. The order is set aside as Competitive 8(a) and carries a firm fixed price.
Kaiva Strategies is a tribally-owned, minority-owned 8(a) small business. Place of performance is Silver Spring, MD. The order's ultimate completion date is September 29, 2028. The PACS IDIQ, a $100 million Competitive 8(a) single-award vehicle running through August 2028, supports professional, administrative, and consulting services to FDA across multiple delivery orders and task orders. Kaiva operates primarily as a managed service delivery vehicle, leveraging specialized labor partners; across SCI-reportable prime contracts, subcontractors performed an average of 70 percent of contractor hours.
Quick answers
Who was awarded contract 75F40126F19039?
75F40126F19039 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126F19039 worth?
The government has obligated $1,563,773 on 75F40126F19039. Its potential value, with all options, is $2,910,067.
Is contract 75F40126F19039 an order under another contract?
Yes. 75F40126F19039 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40126F19039 competed?
The extent of competition for 75F40126F19039 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award